Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 8.5B | 8.5B | 9.3B | 9.2B |
Cost of revenue | 6.9B | 6.9B | 7.3B | 7.2B |
Gross profit | 1.6B | 1.6B | 2.0B | 1.9B |
Operating expense | ||||
Research & development | 180M | 172M | 192M | 187M |
Selling general and admin | 87M | 96M | 80M | 90M |
Other operating expenses | — | — | — | — |
Operating income | 1.3B | 1.3B | 1.7B | 1.6B |
Non operating interest income | ||||
Income | 31M | 36M | 45M | 52M |
Expense | 142M | 147M | 131M | 136M |
Other income expense | 51M | -164M | -216M | -54M |
Pretax income | 1.3B | 1.1B | 1.4B | 1.5B |
Tax provision | 237M | 234M | 269M | 289M |
Net income | 1.0B | 829M | 1.1B | 1.2B |
Basic EPS | 0.8 | 0.6 | 0.8 | 0.8 |
Diluted EPS | 0.7 | 0.6 | 0.8 | 0.8 |
Basic average shares | 1.4B | 1.4B | 1.4B | 1.4B |
Diluted average shares | 1.4B | 1.4B | 1.4B | 1.4B |
EBITDA | 2.1B | 2.1B | 1.8B | 2.4B |
Net income from continuing op. | 1.0B | 829M | 1.1B | 1.2B |
Minority interests | -34M | -32M | -23M | -32M |
Preferred stock dividends | — | — | — | — |